TT-4
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TT-4, covering 2025-03-18 to 2025-04-02. Get the full timeline:
Most recent: Clinical Trial Update: TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors [Phase 1, Phase 2]